Suspension of trading
Intellipharmaceutics International Inc. Share Price
Stocks
I4AA
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0445 EUR | -13.59% |
|
-.--% | - |
| Market Cap | 1.28M 1.13M 1.04M 970K 1.82M 121M 1.85M 12.44M 4.82M 59.6M 4.81M 4.71M 207M | P/E 2021 |
-0.4x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 3.52M 3.1M 2.85M 2.67M 5M 332M 5.09M 34.21M 13.25M 164M 13.23M 12.94M 570M | EV / Sales 2021 |
-
| EV / Sales 2022 | 74x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -13.59% |
| 3 years | 0.02 |  | 0.08 |
| 5 years | 0.01 | | 0.18 |
| 10 years | 0.01 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 31/03/2007 | |
| Corporate Officer/Principal | - | 31/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 31/08/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/02/24 | Option | Director | 100,000 | 0.3022% | ||
| 12/02/24 | Option | Executive/Senior Manager | 200,000 | 0.6044% | ||
| 12/02/24 | Option | Director | 120,000 | 0.3626% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.59% | -.--% | -.--% | +11.25% | 1.52M | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -0.73% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.33% | +5.98% | +38.27% | +24.21% | 288B | |
| -1.21% | +5.38% | +29.83% | +40.19% | 285B | |
| -2.00% | +5.75% | -28.11% | -42.36% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| Average | -1.23% | +5.25% | +24.63% | +44.24% | 348.58B | |
| Weighted average by Cap. | +0.64% | +5.38% | +35.15% | +70.27% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73K 57.74K 53.19K 49.74K 93.28K 6.2M 95K 638K 247K 3.06M 247K 241K 10.62M |
| Net income | -5.15M -4.52M -4.16M -3.89M -7.3M -485M -7.44M -49.96M -19.35M -239M -19.32M -18.9M -832M | -2.89M -2.54M -2.34M -2.19M -4.11M -273M -4.18M -28.09M -10.88M -135M -10.86M -10.62M -468M |
| Net Debt | 1.15M 1.01M 927K 867K 1.63M 108M 1.66M 11.12M 4.31M 53.28M 4.3M 4.21M 185M | 2.24M 1.97M 1.81M 1.7M 3.18M 212M 3.24M 21.77M 8.43M 104M 8.42M 8.24M 362M |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- I4AA Stock
Select your edition
All financial news and data tailored to specific country editions
